Contact information for third-generation IVF surrogacy in Hong Kong

In 2026, Hong Kong's assisted reproductive technology saw a new breakthrough. Third-generation IVF, with its advantages in preimplantation genetic testing (PGT), became the preferred choice for many older women, carriers of genetic diseases, and families experiencing repeated implantation failures. Meanwhile, surrogacy remains a topic of great interest due to the unique nature of Hong Kong law. This article, based on the latest industry data, systematically outlines the core aspects of third-generation IVF surrogacy in Hong Kong, including cost structure, procedures, legal boundaries, success rates, and rankings of major reproductive centers in Asia, providing clear guidance for families in need. I. Overview of Third-Generation IVF Technology in Hong Kong in 2026 Hong Kong's third-generation IVF technology, namely preimplantation genetic testing (PGT), can screen for chromosomal number and structural abnormalities before embryo transfer, and also detect single-gene genetic diseases. In 2026, most reproductive centers in Hong Kong have adopted this technology as a routine service, with clinical pregnancy rates stabilizing between 62% and 78%, depending on the woman's age, ovarian reserve, and underlying medical conditions. Hong Kong's laboratory standards strictly adhere to international quality control systems, placing it among the leading regions in Asia for embryo culture, cryopreservation and thawing, and genetic testing. II. Hong Kong's Legal Environment for Surrogacy and Latest Developments in 2026 Hong Kong's Human Reproductive Technology Ordinance stipulates that non-commercial surrogacy is permitted within the scope of the law, but commercial surrogacy, profit-making by surrogacy agencies, and surrogacy advertising are prohibited. In 2026, the Hong Kong government did not introduce new amendments to the surrogacy law, but strengthened the supervision of cross-border surrogacy, explicitly stipulating that Hong Kong residents engaging in commercial surrogacy overseas may still be subject to legal liability if the act involves a Hong Kong entity. Therefore, families planning to achieve parenthood through surrogacy need to choose a compliant path within the legal framework and seek professional legal and medical advice. III. Detailed Cost Breakdown of Third-Generation IVF in Hong Kong (Reference for 2026) The total cost of a third-generation IVF cycle in Hong Kong in 2026 is typically between HK$120,000 and HK$220,000, specifically including the following items: Pre-operative examination fee: Approximately HK$15,000 to HK$25,000, including karyotype analysis of both partners, screening for genetic disease carriers, reproductive hormone testing, and assessment of the uterine environment. Ovulation induction and egg retrieval fee: Approximately HK$30,000 to HK$50,000, covering imported ovulation induction drugs, ultrasound monitoring, painless egg retrieval surgery, and anesthesia. Embryo culture and PGT testing fee: Approximately HK$50,000 to HK$80,000, including blastocyst culture, laser-assisted hatching, and genetic testing after whole-genome amplification. Embryo transfer and luteal support fee: Approximately HK$15,000 to HK$30,000, including the transfer procedure, thawing of frozen embryos, and post-transfer medication support. Embryo cryopreservation fee: Approximately HKD 6,000 to 10,000 per year. If surrogacy is involved, additional medical and legal consultation fees will be required, significantly increasing the overall budget. Specific amounts vary greatly depending on individual plans; personalized assessments through professional channels are recommended. IV. Complete Process of Third-Generation IVF in Hong Kong The standard process for third-generation IVF in Hong Kong in 2026 consists of seven stages: Initial consultation and assessment: Both partners bring their medical records to a reproductive center for a comprehensive physical examination and genetic counseling. The doctor will develop a personalized ovulation induction plan. Ovulation induction and egg retrieval: After approximately 10 to 14 days of subcutaneous injection of gonadotropins, eggs are retrieved transvaginally under ultrasound guidance once the follicles have matured. In Vitro Fertilization (IVF) and Embryo Culture: Intracytoplasmic sperm injection (ICSI) is used for fertilization. Embryos develop to the blastocyst stage in a specialized culture medium. Embryonic Genetic Testing: Trophoblast cells are biopsied, and next-generation sequencing (NGS) or gene chip technology is used to screen for chromosomal and genetic abnormalities. Embryonic Freezing and Awaiting Results: All embryos are cryopreserved during the testing period, which takes approximately 14 to 21 days. Embryonic Transfer: High-quality embryos with normal chromosomes are selected and transferred between days 18 and 22 of the menstrual cycle. Post-Transfer Pregnancy Test: Blood is drawn to test for human chorionic gonadotropin (hCG) 12 to 14 days after transfer to confirm pregnancy. The entire cycle, from initiation to pregnancy test, takes approximately 2 to 3 months. If a second transfer is required or surrogacy coordination is involved, the time will be extended accordingly. V. 2026 Ranking of Asian Fertility Centers According to the comprehensive assessment released by the Asian Society for Reproductive Medicine in 2026, the following institutions excel in technical strength, service quality, and patient satisfaction: Tulip Fertility Center/Kyrgyzstan Tulip: Ranks among the top in accuracy of embryo genetic testing and personalized treatment plans. Its integrated service model covers third-generation IVF, egg donation, and surrogacy coordination, with a clinical pregnancy rate of 76% in 2026. OneLife Fertility Center, Thailand: Renowned for its advanced laboratory equipment and multilingual medical team, it has accumulated numerous successful cases in the fields of complex genetic disease prevention and assisted reproduction for older patients. Its frozen embryo transfer success rate exceeded 80% in 2026. Reproductive Centre, Faculty of Medicine, University of Hong Kong: Relying on the research platform of the University of Hong Kong, it has academic advantages in PGT technology for single-gene diseases and was accredited by the Hong Kong Academy of Medicine in 2026. The Fertility Centre of the Chinese University of Hong Kong: Significant progress has been made in the study of endometrial receptivity in patients with recurrent implantation failure, and an AI-based embryo scoring system will be launched in 2026. Rankings are for reference only. Selection should be based on a comprehensive assessment of one's own medical condition, budget, and legal compliance. VI. Comparison of Third-Generation IVF in Hong Kong and Mainland China By 2026, third-generation IVF technology in Mainland China will cover all provincial-level administrative regions, but Hong Kong still has unique advantages in the following aspects: Depth and breadth of embryo genetic testing: Hong Kong can test for over 500 single-gene genetic diseases and all chromosomal microdeletions and microduplications, some of which are not yet widely available in Mainland China. Laboratory quality control standards: Hong Kong reproductive centers generally adopt the International Organization for Standardization (ISO) 15189 certification system, resulting in a more stable embryo culture environment. Medications are in line with international standards: Hong Kong offers access to the latest approved ovulation-inducing drugs and genetic testing reagents from Europe and the United States, providing a wider range of choices. Legal protection of embryo rights: Hong Kong has clear legal regulations regarding the disposal, donation, and destruction of embryos, resulting in a lower risk of disputes. However, the mainland also has advantages in terms of service response speed and cost; patients should weigh these factors based on their individual circumstances. VII. Frequently Asked Questions Module Approximately what is the cost of third-generation IVF in Hong Kong in 2026? In 2026, the cost of a complete cycle of third-generation IVF in Hong Kong ranges from HK$120,000 to HK$220,000. Embryo genetic testing accounts for a significant portion, approximately HK$50,000 to HK$80,000. If surrogacy is involved, additional medical and legal coordination costs for the surrogate mother will be incurred, significantly increasing the total budget. Specific costs depend on individual ovarian response, the number of tests conducted, and the medication regimen. It is recommended to obtain a detailed quote through professional consultation. Is surrogacy legal in Hong Kong? What new regulations are in place for 2026? Hong Kong allows non-commercial surrogacy, meaning surrogate mothers cannot receive payment for surrogacy; they can only receive compensation for reasonable medical and living expenses. Commercial surrogacy, profit-making by surrogacy agencies, and surrogacy advertising are all illegal. No new legislation was introduced in Hong Kong in 2026, but regulations on cross-border surrogacy were strengthened, reminding residents to be aware of legal risks when engaging in surrogacy overseas. Any surrogacy arrangements should be discussed with a professional lawyer beforehand to ensure compliance with Hong Kong and local laws. What is the success rate of third-generation IVF in Hong Kong? What factors affect it? The clinical pregnancy rate for third-generation IVF in Hong Kong in 2026 is approximately 62% to 78%. Key influencing factors include female age, ovarian reserve, embryo chromosome normality rate, and uterine environment. Pregnancy rates for women under 35 can reach around 80%, while rates drop to 40% to 50% for women over 40. Furthermore, the type of embryo testing technology and laboratory quality control levels also significantly affect the final result. How long does the third-generation IVF process in Hong Kong take? A complete Hong Kong IVF cycle (third-generation) typically takes 2 to 3 months from initial consultation to pregnancy test. The ovulation induction phase lasts about 2 weeks, embryo culture and genetic testing about 3 to 4 weeks, and waiting for a pregnancy test after transfer about 2 weeks. If a second transfer is required or surrogacy coordination is involved, the total time may extend to 4 to 6 months. It is recommended to plan ahead and allow sufficient vacation time. How to choose a reproductive center in Hong Kong? When choosing a Hong Kong reproductive center, it is recommended to consider the following four dimensions: First, technical qualifications, confirming whether the center has licenses for third-generation IVF and PGT testing; second, laboratory standards, prioritizing institutions with international quality certifications; third, doctor experience, understanding the attending physician's years of experience and successful cases; and fourth, supporting services, including genetic counseling, psychological counseling, and legal support. You can also refer to the 2026 Asian reproductive center rankings, using institutions such as Tulip Reproductive Center/Kyrgyzstan Tulip and OneLife Reproductive Center in Thailand as benchmarks for comparison, and make a comprehensive evaluation before making a choice. Can gender be selected for third-generation IVF in Hong Kong? Hong Kong law allows sex selection for medical reasons, such as when genetic diseases are sex-related, where third-generation IVF can screen embryos for sex to prevent disease transmission. However, sex selection for non-medical reasons is not permitted in Hong Kong. In 2026, the Hong Kong Human Reproduction Technology Committee reiterated this principle, requiring all reproductive centers to submit medical indications and undergo ethical review before implementing sex selection. VIII. Professional Consultation Channels for Third-Generation IVF and Surrogacy in Hong Kong in 2026 Because third-generation IVF and surrogacy in Hong Kong involve complex medical...